Form 4: NeuroPace CEO Joel Becker's Routine Stock Transaction
Insider Transaction Report
NeuroPace Inc. CEO Joel Becker reported a disposition of 1,126 common shares to cover tax obligations related to a restricted stock unit award vesting.
Summary
- Joel Becker, Chief Executive Officer and Director of NeuroPace Inc. (NPCE), reported a transaction on November 27, 2025.
- 1,126 shares of NeuroPace Inc. common stock were disposed of at a price of $16.5 per share.
- This disposition represents shares withheld by the issuer to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.
- Following this transaction, Joel Becker beneficially owns 103,086 shares of NeuroPace Inc. common stock.
Sentiment
Score: 6
Explanation: The filing reports a routine insider transaction where shares were withheld for tax purposes upon the vesting of restricted stock units, which is a standard compensation event for executives. This is generally a neutral event for the company's operational or financial performance.
Positives
- The vesting of a restricted stock unit award for CEO Joel Becker indicates a successful compensation event for the executive.
Negatives
- No direct negative impacts on the company's operations or financial health are indicated by this routine tax withholding transaction.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Disposition of 1,126 common shares by CEO Joel Becker to NeuroPace Inc. to satisfy tax withholding obligations related to restricted stock unit vesting.
Stakeholder Impact
- Shareholders: This is a routine compensation-related transaction and does not indicate any material change in company operations or strategy. It reflects the normal functioning of executive equity compensation plans.
- Employees: No direct impact on the broader employee base is indicated by this executive-level transaction.
Key Dates
| Date | Description |
|---|---|
| 11/27/2025 | Transaction Date: Shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
| 12/01/2025 | Signature Date of Reporting Person's Attorney-in-Fact. |
Recommendation
holdThis Form 4 details a routine tax withholding transaction for an executive's restricted stock unit vesting. It does not provide new operational or financial information that would warrant a change in investment recommendation. Investors should continue to evaluate NeuroPace Inc. based on its core business performance and broader market conditions.
Keywords
NeuroPace, NPCE, Form 4, insider transaction, stock, CEO, Joel Becker, tax withholding, RSU
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.